| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/16/2009 | US20090099339 Antibody and antibody fragments for inhibiting the growth of tumors |
| 04/16/2009 | US20090099336 using the conjugates in the inhibition of cell growth; cancer; monoclonal antibody or epitope-binding fragment thereof, that recognizes and binds the CA6 glycotope |
| 04/16/2009 | US20090099134 Treatment of dna damage related disorders |
| 04/16/2009 | US20090099081 Synthetic axmi-004 delta-endotoxin genes and methods for their use |
| 04/16/2009 | US20090099079 Novel Fungal Enzymes |
| 04/16/2009 | US20090099078 Nogo Receptor Antagonists |
| 04/16/2009 | US20090099072 Motif of the Beclin Protein Which Interacts with Anti-Apoptotic Members of the Bcl-2 Protein Family, and Uses |
| 04/16/2009 | US20090098631 Novel glutamic acid decarboxylase (GAD) proteins and methods of use |
| 04/16/2009 | US20090098629 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine; 22P4F11 transcript and/or protein represent a useful diagnostic marker and/or therapeutic target for prostate cancer |
| 04/16/2009 | US20090098610 useful as a reagent for genetic engineering, DNA sequencing, labeling, site-directed mutagenesi; culturing a cell capable of producing a polypeptide, and collecting such polypeptide from the culture |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098608 Methods, systems and reagents for improved immunodetection |
| 04/16/2009 | US20090098583 Methods of detecting early renal disease in animals |
| 04/16/2009 | US20090098581 Tyrosine phosphorylation sites |
| 04/16/2009 | US20090098580 Mammalian sweet taste receptors |
| 04/16/2009 | US20090098579 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception |
| 04/16/2009 | US20090098576 Feline Pancreatic Lipase |
| 04/16/2009 | US20090098575 antiidiotypic, chimeric, humanized, monoclonal or polyclonal antibodies or faragments that specifically binds polypeptides having synthetase enzyme activity |
| 04/16/2009 | US20090098572 detecting a rhesus monkey BCRP polypeptide in a sample; used as a hematopoietic stem cell marker |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098568 Method for immobilizing proteins |
| 04/16/2009 | US20090098544 Marker molecules associated with lung tumors |
| 04/16/2009 | US20090098528 Method for determining early HCV seroconversion |
| 04/16/2009 | US20090098166 Chimeric MSP-based malaria vaccine |
| 04/16/2009 | US20090098164 Spore associated display |
| 04/16/2009 | US20090098150 Anti-acetylated huntingtin antibodies and uses therof |
| 04/16/2009 | US20090098148 High efficiency tissue-specific compound delivery system using streptavadin-protein a fusion protein |
| 04/16/2009 | US20090098144 Immunogen presenting hiv gp120 v3 loop in a conformation that induces broadly neutralizing antibodies |
| 04/16/2009 | US20090098140 Monoclonal antibodies and their use |
| 04/16/2009 | US20090098134 Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies |
| 04/16/2009 | US20090098132 Composition and method for treating lupus nephritis |
| 04/16/2009 | US20090098131 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098129 Member of the TNF Ligand Family |
| 04/16/2009 | US20090098128 NPC1L1 orthologues |
| 04/16/2009 | US20090098127 Agents Capable of Downregulating an MSF-A DEPENDENT HIF-1ALPHA and Use Thereof in Cancer Treatment |
| 04/16/2009 | US20090098126 Method and kit for the detection of adenoviruses |
| 04/16/2009 | US20090098125 PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 04/16/2009 | US20090098124 Identification and engineering of antibodies with variant heavy chains and methods of using same |
| 04/16/2009 | US20090098123 Hcv coreceptor and methods of use thereof |
| 04/16/2009 | US20090098122 sRAGE Mimetibody, Compositions, Methods and Uses |
| 04/16/2009 | US20090098121 Monoclonal antibody fusion comprising bactericidal agent for use in targeted destruction of microorganisms; for use in health care, veterinary medicine and food processing |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098119 Antidotes for factor xa inhibitors and methods of using the same |
| 04/16/2009 | US20090098117 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 04/16/2009 | US20090098116 Immunogenic compositions for induction of anti-tumor immunity |
| 04/16/2009 | US20090098112 Novel antibodies |
| 04/16/2009 | US20090098109 Compositions and Methods For Enhancing Neuronal Plasticity and Regeneration |
| 04/16/2009 | US20090098106 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-kB ACTIVITY |
| 04/16/2009 | US20090098100 Hormonally up-regulated, neu-tumor-associated kinase |
| 04/16/2009 | US20090098054 Methods and compositions relating to promoter regulation by muc1 and klf proteins |
| 04/16/2009 | US20090098053 La1 - the genome of a lactobacillus strain |
| 04/16/2009 | US20090098051 Bacillus thuringiensis toxin |
| 04/16/2009 | US20090098045 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 04/16/2009 | DE19520398B4 Magnetisches Pigment Magnetic pigment |
| 04/16/2009 | CA2702230A1 Method and kit for rapid isolation of human foxp3+ treg cells |
| 04/16/2009 | CA2702217A1 Modulation of sirp.alpha. - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 04/16/2009 | CA2702005A1 Compositions and methods for use for antobodies against sclerostin |
| 04/16/2009 | CA2701793A1 Monoclonal antibody |
| 04/16/2009 | CA2701790A1 Humanized antibody |
| 04/16/2009 | CA2701788A1 Humanized antibody |
| 04/16/2009 | CA2701677A1 Cho-k1 cell line |
| 04/16/2009 | CA2701646A1 Protein expression from multiple nucleic acids |
| 04/16/2009 | CA2698326A1 Antibody targeting osteoclast-related protein siglec-15 |
| 04/15/2009 | EP2048505A2 Method for early recognition of the seroconversion of an antibody to hepatitis C |
| 04/15/2009 | EP2048501A1 Antibody specific to intact human autotaxin, method of screening the same and method and reagent for examining malignant lymphoma by assaying autotaxin |
| 04/15/2009 | EP2048239A1 Glyceroglycolipid antigen of mycoplasma pneumoniae |
| 04/15/2009 | EP2048235A2 Synthetic Mammalian Alpha-N-Acetylglucosaminidase and Genetic Sequences Encoding Same |
| 04/15/2009 | EP2048230A1 Cell death inducer |
| 04/15/2009 | EP2048225A1 Method and kit for rapid isolation of human Foxp3+treg cells |
| 04/15/2009 | EP2048163A1 Antihuman alpha- 9 integrin antibody and use of the same |
| 04/15/2009 | EP2048162A1 Novel monoclonal antibody and use of the same |
| 04/15/2009 | EP2048161A1 Monoclonal antibody to soluble lox-1 |
| 04/15/2009 | EP2048157A1 Polynucleotide encoding the rg1 polypeptide |
| 04/15/2009 | EP2048154A1 Protein purification |
| 04/15/2009 | EP2047863A1 Preventive or remedy for inflammatory disease |
| 04/15/2009 | EP2047862A1 Remedy for renal disease |
| 04/15/2009 | EP2047263A2 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes |
| 04/15/2009 | EP2046965A2 Knockout mice for different genes and their use for gene characterization |
| 04/15/2009 | EP2046836A1 Antibody specifically binding to dr5 and composition for preventing or treating cancers comprising the same |
| 04/15/2009 | EP2046835A2 Antibodies to il-17a |
| 04/15/2009 | EP2046834A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 04/15/2009 | EP2046833A2 Humanized antibody against amyloid beta |
| 04/15/2009 | EP2046832A1 Single chain fc polypeptides |
| 04/15/2009 | EP2046831A2 Novel multivalent immunoglobulins |
| 04/15/2009 | EP2046823A1 Post-translationally modified neurotrophins |
| 04/15/2009 | EP2046818A2 Method of selective protein enrichment and associated applications |
| 04/15/2009 | EP2046809A2 Wsx-1/p28 as a target for anti-inflammatory responses |
| 04/15/2009 | EP2046385A2 Composition for modulating the expression of cell adhesion molecules |
| 04/15/2009 | EP2046384A2 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof |
| 04/15/2009 | EP2046383A1 Cd20 binding molecules for the treatment of copd |
| 04/15/2009 | EP2046382A2 scFv ANTIBODIES WHICH PASS EPITHELIAL AND/OR ENDOTHELIAL LAYERS |
| 04/15/2009 | EP2046381A1 Cancerous disease modifying antibodies |
| 04/15/2009 | EP2046377A1 Method of protecting against staphylococcal infection |
| 04/15/2009 | EP2046375A2 Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting |
| 04/15/2009 | EP1828405A4 Methods of detecting an analyte in a sample |
| 04/15/2009 | EP1745129B1 Antibodies against canine pancreatic lipase |
| 04/15/2009 | EP1606388A4 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 04/15/2009 | EP1562628B1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 04/15/2009 | EP1523503B1 Therapeutic antibodies with reduced side effects |
| 04/15/2009 | EP1505148B1 Methods of screening for agonistic antibodies |